Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer. This evidence concerns the gene SLC38A2 and triple-negative breast carcinoma.